Rebecca M Brown

Dr. Rebecca M Brown

neurology, Icahn School of Medicine at Mount Sinai, New York, USA
orcid
Clinical Assistant Professor, Division of Neuro-Oncology, Th...

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2008 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
Rebecca M BrownRebecca M Brown
Rebecca M Brown
DWDeena M. Walker
Deena M. Walker
TJThomas E. Juenger
Thomas E. Juenger
MWMichael J. Woller
Michael J. Woller
Andrea C. GoreAndrea C. Gore
Andrea C. Gore
Perinatal exposures to endocrine-disrupting chemicals, such as polychlorinated biphenyls (PCBs), can cause latent effects on reproductive function. He

1 March 2007 in Hormones and Behavior
Verified
Journal Article
Closed access
Rebecca M BrownRebecca M Brown
Rebecca M Brown
TJThomas E. Juenger
Thomas E. Juenger
Andrea C. GoreAndrea C. Gore
Andrea C. Gore

1 August 2021 in Cell Stem Cell
Verified
Journal Article
Closed access
DSDaochun Sun
Daochun Sun
Xuanhua XieXuanhua Xie
Xuanhua Xie
XZXiyuan Zhang
Xiyuan Zhang
ZWZilai Wang
Zilai Wang
SSSameer Farouk Sait
Sameer Farouk Sait
LPLuis F. Parada
Luis F. Parada

1 April 2024 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
SLShaan Lalvani
Shaan Lalvani
Rebecca M BrownRebecca M Brown
Rebecca M Brown
Neurofibromatosis Type I (NF1) is a complex genetic condition that affects multiple organ systems and presents a unique set of challenges for clinicians in its management. NF1 is a tumor predisposition syndrome that primarily affect the peripheral and central nervous systems via the impact of haploinsufficiency upon neural crest lineage cells including Schwann cells, melanocytes, fibroblasts, etc. NF1 can further lead to pathology of the skin, bones, visual system, and cardiovascular system, all of which can drastically reduce a patient’s quality of life (QOL). This review provides a comprehensive examination of the many specialties required for the care of patients with Neurofibromatosis Type 1 (NF1). We delve into the pathogenesis and clinical presentation of NF1, highlighting its diverse manifestations and the challenges they pose in management. The review underscores the importance of a multidisciplinary approach to NF1, emphasizing how such an approach can significantly improve patient outcomes and overall QOL. Central to this approach is the role of the NF expert, who guides a multidisciplinary team (MDT) comprising healthcare professionals from many areas of expertise. The MDT collaboratively addresses the multifaceted needs of NF1 patients, ensuring comprehensive and personalized care. This review highlights the need for further investigation to optimize the workflow for NF1 patients in an MDT setting, and to improve implementation and efficacy.

31 October 2023 in Current Oncology Reports
Verified
Journal Article
Closed access
PDF file
Rebecca M BrownRebecca M Brown
Rebecca M Brown

16 May 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DPDina Michelle Poplausky
Dina Michelle Poplausky
JYJade N. Young
Jade N. Young
HTHansen Tai
Hansen Tai
RRRyan Rivera-Oyola
Ryan Rivera-Oyola
NGNicholas Gulati
Nicholas Gulati
Rebecca M BrownRebecca M Brown
Rebecca M Brown
Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome that increases one’s risk for both benign and malignant tumors. NF1 affects every organ in the body, but the most distinctive symptoms that are often the most bothersome to patients are the cutaneous manifestations, which can be unsightly, cause pain or pruritus, and have limited therapeutic options. In an effort to increase awareness of lesser-known dermatologic associations and to promote multidisciplinary care, we conducted a narrative review to shed light on dermatologic associations of NF1 as well as emerging treatment options. Topics covered include cutaneous neurofibromas, plexiform neurofibromas, diffuse neurofibromas, distinct nodular lesions, malignant peripheral nerve sheath tumors, glomus tumors, juvenile xanthogranulomas, skin cancer, and cutaneous T-cell lymphoma.